Bleomycin administered by laser-assisted drug delivery or intradermal needle-injection results in distinct biodistribution patterns in skin: in vivo investigations with mass spectrometry imaging

Bleomycin (BLM) is being repositioned in dermato-oncology for intralesional and intra-tumoural use. Although conventionally administered by local needle injections (NIs), ablative fractional lasers (AFLs) can facilitate topical BLM delivery. Adding local electroporation (EP) can augment intracellula...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendel, Kristoffer, Hansen, Anders C. N., Bik, Liora, Bagger, Charlotte, van Doorn, Martijn B. A., Janfelt, Christian, Olesen, Uffe H., Haedersdal, Merete, Lerche, Catharina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205002/
https://www.ncbi.nlm.nih.gov/pubmed/34121567
http://dx.doi.org/10.1080/10717544.2021.1933649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205002/
https://www.ncbi.nlm.nih.gov/pubmed/34121567
http://dx.doi.org/10.1080/10717544.2021.1933649

Ejemplares similares